Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>News>This Article
  News
Return

Apitope Completes Recruitment into its Clinical Trial of ATX-MS-1467 in MS

Published: Monday, November 26, 2012
Last Updated: Monday, November 26, 2012
Bookmark and Share
ATX-MS-1467 dosing expected to be complete by the end of 2012.


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here


Scientific News
Adults Only Really Catch Flu About Twice a Decade, Suggests Study
Researchers developed a mathematical model of how our immunity to flu changes over a lifetime as we encounter different strains of the virus.
NIH Announces $41.5 Million in Funding for the Human Placenta Project
Better understanding of the placenta promises to improve the health of mothers and children.
Scientists Uncover New Role for Neurotransmitter that Helps Fight Infection
Scientists have shed new light on the complexities of the immune system that could help develop vaccines to boost natural defences against disease.
NIH-funded Scientists Create Potential Long-acting HIV Therapeutic
New molecule also might prevent HIV infection.
Epigenetic Study Highlights Drug Targets for Allergies and Asthma
Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.
Epigenomics of Alzheimer’s Disease Progression
Study of epigenomic modifications reveals immune basis of Alzheimer's disease.
Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases Revealed
Findings point to potential drug targets.
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
Researchers Find New Mechanism That Controls Immune Responses
The findings appear online in the journal Science.
The Company You Keep
La Jolla Institute scientists reveal dual role for key T cell factor.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters